Vera Therapeutics Inc
NASDAQ:VERA
Vera Therapeutics Inc
NASDAQ:VERA
Price:
37.99 USD
2.81%
Market Closed
Updated:
Jun 3, 2024
Vera Therapeutics Inc
Common Shares Outstanding
|
Vera Therapeutics Inc
Common Shares Outstanding Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Common Shares Outstanding Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Common Shares Outstanding | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Vera Therapeutics Inc
NASDAQ:VERA
|
Common Shares Outstanding
$44.5m
|
CAGR 3-Years
29%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Common Shares Outstanding
$1.8B
|
CAGR 3-Years
0%
|
CAGR 5-Years
4%
|
CAGR 10-Years
1%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Common Shares Outstanding
$1.2B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-2%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Common Shares Outstanding
$536.4m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-3%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Common Shares Outstanding
$258.3m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
1%
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Common Shares Outstanding
$110.2m
|
CAGR 3-Years
1%
|
CAGR 5-Years
0%
|
CAGR 10-Years
1%
|
See Also
What is Vera Therapeutics Inc's Common Shares Outstanding?
Common Shares Outstanding
44.5m
USD
44.5m
USD
Based on the financial report for Dec 31, 2023, Vera Therapeutics Inc's Common Shares Outstanding amounts to 44.5m USD.
What is Vera Therapeutics Inc's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 3Y
29%
29%
Over the last year, the Common Shares Outstanding growth was 60%. The average annual Common Shares Outstanding growth rates for Vera Therapeutics Inc have been 29% over the past three years .
You don't have any saved screeners yet
